Coya Therapeutics (COYA) FCF Margin (2023 - 2025)
Historic FCF Margin for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to 31.72%.
- Coya Therapeutics' FCF Margin changed N/A to 31.72% in Q3 2025 from the same period last year, while for Sep 2025 it was 304.48%, marking a year-over-year decrease of 1985600.0%. This contributed to the annual value of 289.49% for FY2024, which is 1030800.0% down from last year.
- Coya Therapeutics' FCF Margin amounted to 31.72% in Q3 2025.
- Over the past 5 years, Coya Therapeutics' FCF Margin peaked at 1691.82% during Q1 2024, and registered a low of 123451.18% during Q4 2024.
- Its 3-year average for FCF Margin is 18083.85%, with a median of 133.23% in 2024.
- Per our database at Business Quant, Coya Therapeutics' FCF Margin plummeted by -1234138400bps in 2024 and then crashed by -27885500bps in 2025.
- Quarter analysis of 3 years shows Coya Therapeutics' FCF Margin stood at 37.34% in 2023, then tumbled by -330535bps to 123451.18% in 2024, then soared by 100bps to 31.72% in 2025.
- Its FCF Margin was 31.72% in Q3 2025, compared to 3528.56% in Q2 2025 and 1096.72% in Q1 2025.